Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography

被引:85
|
作者
Rusjan, Pablo M. [1 ]
Wilson, Alan A. [1 ,2 ]
Bloomfield, Peter M. [1 ]
Vitcu, Irina [1 ]
Meyer, Jeffrey H. [1 ,2 ]
Houle, Sylvain [1 ,2 ]
Mizrahi, Romina [1 ,2 ]
机构
[1] CAMH, PET Ctr, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
来源
基金
加拿大创新基金会;
关键词
inflammation; kinetic modeling; microglia; mitochondria; positron emission tomography; PERIPHERAL BENZODIAZEPINE-RECEPTOR; CEREBRAL BLOOD-FLOW; 18; KDA; PET; MICROGLIA; SITES; MODEL; LIGAND; VOLUME; VISUALIZATION;
D O I
10.1038/jcbfm.2011.55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article describes the kinetic modeling of [F-18]-FEPPA binding to translocator protein 18 kDa in the human brain using high-resolution research tomograph (HRRT) positron emission tomography. Positron emission tomography scans were performed in 12 healthy volunteers for 180 minutes. A two-tissue compartment model (2-CM) provided, with no exception, better fits to the data than a one-tissue model. Estimates of total distribution volume (V-T), specific distribution volume (V-S), and binding potential (BPND) demonstrated very good identifiability (based on coefficient of variation (COV)) for all the regions of interest (ROIs) in the gray matter (COV V-T < 7%, COV V-S < 8%, COV BPND < 11%). Reduction of the length of the scan to 2 hours is feasible as V-S and V-T showed only a small bias (6% and 7.5%, respectively). Monte Carlo simulations showed that, even under conditions of a 500% increase in specific binding, the identifiability of V-T and V-S was still very good with COV < 10%, across high-uptake ROIs. The excellent identifiability of V-T values obtained from an unconstrained 2-CM with data from a 2-hour scan support the use of V-T as an appropriate and feasible outcome measure for [F-18]-FEPPA. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 1807-1816; doi:10.1038/jcbfm.2011.55; published online 27 April 2011
引用
收藏
页码:1807 / 1816
页数:10
相关论文
共 50 条
  • [41] Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects
    Andrea Varrone
    Vesa Oikonen
    Anton Forsberg
    Juho Joutsa
    Akihiro Takano
    Olof Solin
    Merja Haaparanta-Solin
    Sangram Nag
    Ryuji Nakao
    Nabil Al-Tawil
    Lisa A. Wells
    Eugenii A. Rabiner
    Ray Valencia
    Marcus Schultze-Mosgau
    Andrea Thiele
    Sonja Vollmer
    Thomas Dyrks
    Lutz Lehmann
    Tobias Heinrich
    Anja Hoffmann
    Agneta Nordberg
    Christer Halldin
    Juha O. Rinne
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 438 - 446
  • [42] Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects
    Varrone, Andrea
    Oikonen, Vesa
    Forsberg, Anton
    Joutsa, Juho
    Takano, Akihiro
    Solin, Olof
    Haaparanta-Solin, Merja
    Nag, Sangram
    Nakao, Ryuji
    Al-Tawil, Nabil
    Wells, Lisa A.
    Rabiner, Eugenii A.
    Valencia, Ray
    Schultze-Mosgau, Marcus
    Thiele, Andrea
    Vollmer, Sonja
    Dyrks, Thomas
    Lehmann, Lutz
    Heinrich, Tobias
    Hoffmann, Anja
    Nordberg, Agneta
    Halldin, Christer
    Rinne, Juha O.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (03) : 438 - 446
  • [43] Synthesis and evaluation of [18F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B)
    Nag, S.
    Lehmann, L.
    Kettschau, G.
    Heinrich, T.
    Thiele, A.
    Varrone, A.
    Gulyas, B.
    Halldin, C.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (09) : 3065 - 3071
  • [44] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    Ly, K. H.
    Vidal, E.
    [J]. REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 417 - 427
  • [45] Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in human brain using positron emission tomography
    Leah P. Dickstein
    Sami S. Zoghbi
    Yota Fujimura
    Masao Imaizumi
    Yi Zhang
    Victor W. Pike
    Robert B. Innis
    Masahiro Fujita
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 352 - 357
  • [46] Focusing on [18F]-fluorinated pentoses for positron emission tomography
    Li, Xiang-Guo
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [47] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (10): : 511 - 522
  • [48] Labeling Strategies of Peptides with 18F for Positron Emission Tomography
    Olberg, D. E.
    Hjelstuen, O. K.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (16) : 1669 - 1679
  • [49] Standardization of Scanning for [18F] Fluorodeoxyglucose Positron Emission Tomography
    Hanna, Gerard G.
    McAleese, Jonathan
    Lynch, Tom B.
    O'Sullivan, Joe M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 831 - 832
  • [50] In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography
    Bauer, A
    Holschbach, MH
    Meyer, PT
    Boy, C
    Herzog, H
    Olsson, RA
    Coenen, HH
    Zilles, K
    [J]. NEUROIMAGE, 2003, 19 (04) : 1760 - 1769